Cognitive profile of elderly patients with mild stroke.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3243639)

Published in Dement Geriatr Cogn Dis Extra on November 18, 2011

Authors

Arne Gramstad1, Dag Aarsland, Halvor Naess

Author Affiliations

1: Department of Neurology, Haukeland University Hospital, University of Bergen, Bergen.

Articles cited by this

"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74

Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03

The mini-mental state examination: a comprehensive review. J Am Geriatr Soc (1992) 15.32

Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA (1993) 12.83

Executive function and the frontal lobes: a meta-analytic review. Neuropsychol Rev (2006) 3.50

The elusive nature of executive functions: a review of our current understanding. Neuropsychol Rev (2007) 3.36

Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke (2010) 1.96

Neuropsychological assessment of dementia. Annu Rev Psychol (2009) 1.76

Poststroke memory function in nondemented patients: a systematic review on frequency and neuroimaging correlates. Stroke (2006) 1.69

Stroop performance in focal lesion patients: dissociation of processes and frontal lobe lesion location. Neuropsychologia (2001) 1.52

The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit? J Neurol Sci (2004) 1.46

Neuropathologic alterations in mild cognitive impairment: a review. J Alzheimers Dis (2010) 1.40

Verbal memory in mesial temporal lobe epilepsy: beyond material specificity. Brain (2009) 1.23

Spectrum of anterior cerebral artery territory infarction: clinical and MRI findings. Eur J Neurol (2002) 1.22

Detection of MCI in the clinic: evaluation of the sensitivity and specificity of a computerised test battery, the Hopkins Verbal Learning Test and the MMSE. Age Ageing (2009) 1.20

Contribution of diffusion-weighted imaging in determination of stroke etiology. AJNR Am J Neuroradiol (2006) 1.19

Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J Neurol Neurosurg Psychiatry (2007) 1.17

Cognitive and affective predictors of rehabilitation participation after stroke. Arch Phys Med Rehabil (2010) 1.12

The concept of vascular cognitive impairment. Front Neurol Neurosci (2009) 1.03

Elderly norms for the Hopkins Verbal Learning Test-Revised. Clin Neuropsychol (2000) 1.03

Lateralization of cognitive processes in the brain. Acta Psychol (Amst) (2000) 0.99

How predictive is the MMSE for cognitive performance after stroke? J Neurol (2009) 0.98

Cognitive function following stroke and vascular cognitive impairment. Curr Opin Neurol (2006) 0.91

Word list memory predicts everyday function and problem-solving in the elderly: results from the ACTIVE cognitive intervention trial. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2010) 0.90

The impact of neuropsychological deficits on functional stroke outcomes. Neuropsychol Rev (2006) 0.89

Neuropsychologic assessment of frontal lobe dysfunction. Psychiatr Clin North Am (2005) 0.88

Emotional incontinence and executive function in ischemic stroke: a case-controlled study. J Int Neuropsychol Soc (2009) 0.88

Characterizing the memory changes in persons with mild cognitive impairment. Prog Brain Res (2008) 0.88

Memory profiling in mild cognitive impairment: can we determine risk for Alzheimer's disease? J Neuropsychol (2008) 0.86

Comparison of verbal memory impairment rates in mild cognitive impairment. J Clin Exp Neuropsychol (2010) 0.86

Conceptualizing functional cognition in stroke. Neurorehabil Neural Repair (2007) 0.83

Stroop Color-Word Test performance in patients with Alzheimer's disease. J Clin Exp Neuropsychol (1990) 0.83

High incidence of infarction in the left cerebral hemisphere among young adults. J Stroke Cerebrovasc Dis (2007) 0.81

Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals. J Stroke Cerebrovasc Dis (2009) 0.81

Long-term deficits in episodic memory after ischemic stroke: evaluation and prediction of verbal and visual memory performance based on lesion characteristics. J Stroke Cerebrovasc Dis (2009) 0.78

Exploring cognitive effects of self reported mild stroke in older adults: selective but robust effects on story memory. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2008) 0.78

Early assessment of post-stroke patients entering acute inpatient rehabilitation: utility of the WASI and HVLT-R. Am J Phys Med Rehabil (2002) 0.78

Articles by these authors

(truncated to the top 100)

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA (2009) 7.29

Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord (2007) 6.92

Alzheimer's disease. Lancet (2011) 5.35

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12

Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med (2004) 4.56

Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ (2011) 4.37

Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord (2007) 3.48

Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord (2006) 2.96

A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord (2008) 2.81

Dementia with Lewy bodies. Lancet Neurol (2004) 2.66

Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord (2006) 2.47

Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology (2007) 2.32

Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease. Mov Disord (2014) 2.30

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord (2011) 2.27

A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease. Int J Geriatr Psychiatry (2004) 2.21

Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Mov Disord (2006) 2.04

Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord (2012) 1.99

Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet (2012) 1.88

Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol (2012) 1.86

Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Mov Disord (2008) 1.71

A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol (2010) 1.70

Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.66

Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord (2007) 1.55

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry (2010) 1.55

Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord (2009) 1.54

Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. J Neurol Neurosurg Psychiatry (2009) 1.54

Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology (2005) 1.53

Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord (2003) 1.51

CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2010) 1.50

Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease. Parkinsonism Relat Disord (2007) 1.48

Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS). Int J Geriatr Psychiatry (2008) 1.47

Migraine among Norwegian neurologists. Headache (2012) 1.42

A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry (2006) 1.39

Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol (2004) 1.33

Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF. Proc Natl Acad Sci U S A (2009) 1.32

Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov Disord (2010) 1.31

Hypertension is a potential risk factor for vascular dementia: systematic review. Int J Geriatr Psychiatry (2010) 1.28

The effect of staff training on agitation and use of restraint in nursing home residents with dementia: a single-blind, randomized controlled trial. J Clin Psychiatry (2010) 1.25

Assessment and treatment of pain in people with dementia. Nat Rev Neurol (2012) 1.22

Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited. Neuropsychology (2011) 1.22

Optimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomised controlled trial. PLoS One (2012) 1.21

Who suffers most? Dementia and pain in nursing home patients: a cross-sectional study. J Am Med Dir Assoc (2008) 1.20

Demographic and geographic vascular risk factor differences in European young adults with ischemic stroke: the 15 cities young stroke study. Stroke (2012) 1.20

Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study. J Geriatr Psychiatry Neurol (2005) 1.19

Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms. J Neurol Neurosurg Psychiatry (2007) 1.17

Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'. BMC Neurol (2009) 1.17

Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry (2011) 1.17

The psychosocial burden on spouses of the elderly with stroke, dementia and Parkinson's disease. Int J Geriatr Psychiatry (2002) 1.15

Frequency and correlates of caregiver-reported sleep disturbances in a sample of persons with early dementia. J Am Geriatr Soc (2010) 1.09

Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study. Parkinsonism Relat Disord (2008) 1.08

Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease. Int J Geriatr Psychiatry (2006) 1.08

Time until nursing home admission in people with mild dementia: comparison of dementia with Lewy bodies and Alzheimer's dementia. Int J Geriatr Psychiatry (2013) 1.07

Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation. Neurobiol Dis (2006) 1.06

Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease. Mov Disord (2006) 1.06

Gender-related differences in the burden of non-motor symptoms in Parkinson's disease. J Neurol (2012) 1.05

A novel blood test for the early detection of Alzheimer's disease. J Alzheimers Dis (2011) 1.04

Executive dysfunction in mild cognitive impairment is associated with changes in frontal and cingulate white matter tracts. J Alzheimers Dis (2011) 1.02

The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke. BMC Neurol (2014) 1.02

Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment. J Alzheimers Dis (2013) 1.01

Gray matter correlations of cognition in incident Parkinson's disease. Mov Disord (2010) 1.01

Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. Int J Geriatr Psychiatry (2004) 1.01

Cognitive impairment in nondemented Parkinson's disease. Mov Disord (2011) 1.01

Visual rating of white matter hyperintensities in Parkinson's disease. Mov Disord (2006) 0.98

Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality. Expert Opin Drug Saf (2010) 0.98

Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method. Neurochem Res (2011) 0.97

APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study. J Geriatr Psychiatry Neurol (2009) 0.97

The economic impact of cognitive impairment in Parkinson's disease. Mov Disord (2011) 0.97

Systematic review of services providing information and/or advice to people with dementia and/or their caregivers. Int J Geriatr Psychiatry (2011) 0.97

Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease. Dement Geriatr Cogn Disord (2008) 0.96

Depression in mild dementia: associations with diagnosis, APOE genotype and clinical features. Int J Geriatr Psychiatry (2010) 0.95

Long-term mortality in a cohort of home-dwelling elderly with mild Alzheimer's disease and Lewy body dementia. Dement Geriatr Cogn Disord (2014) 0.94

FMR1 alleles in Parkinson's disease: relation to cognitive decline and hallucinations, a longitudinal study. J Geriatr Psychiatry Neurol (2007) 0.94

Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia. Psychiatry Clin Neurosci (2004) 0.94

Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease. J Neurol Neurosurg Psychiatry (2007) 0.93

Diffusion-weighted lesions in stroke patients with transient symptoms--where are they located? Cerebrovasc Dis (2014) 0.92

The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia. PLoS One (2012) 0.92

Serum albumin in ischemic stroke patients: the higher the better. The Bergen Stroke Study. Cerebrovasc Dis (2009) 0.91

Early and presenting symptoms of dementia with lewy bodies. Dement Geriatr Cogn Disord (2011) 0.91

Risk factors and their impact on carotid intima-media thickness in young and middle-aged ischemic stroke patients and controls: the Norwegian Stroke in the Young Study. BMC Res Notes (2014) 0.88

Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study. BMC Neurol (2011) 0.87

White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease. Neuroimage (2009) 0.87

Intracerebral hemorrhage in southern Norway--a hospital-based incidence study. Eur Neurol (2012) 0.87

Pain and its relationship to depression in Parkinson disease. Am J Geriatr Psychiatry (2009) 0.87

Predictors for recanalization after intravenous thrombolysis in acute ischemic stroke. J Stroke Cerebrovasc Dis (2007) 0.86

The Norwegian Stroke in the Young Study (NOR-SYS): rationale and design. BMC Neurol (2013) 0.86

Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers. Dement Geriatr Cogn Dis Extra (2013) 0.86

Biomarkers Related to Carotid Intima-Media Thickness and Plaques in Long-Term Survivors of Ischemic Stroke. Transl Stroke Res (2015) 0.85

Early supported discharge after stroke in Bergen (ESD Stroke Bergen): a randomized controlled trial comparing rehabilitation in a day unit or in the patients' homes with conventional treatment. Int J Stroke (2012) 0.85

Low body temperature associated with severe ischemic stroke within 6 hours of onset: The Bergen NORSTROKE Study. Vasc Health Risk Manag (2012) 0.85

Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study. J Neurol (2009) 0.85

High prevalence of orthostatic hypotension in mild dementia. Dement Geriatr Cogn Disord (2009) 0.84

Elevated admission blood pressure and stroke severity in acute ischemic stroke: the Bergen NORSTROKE Study. Cerebrovasc Dis (2013) 0.84

Comparison between Ischemic Stroke Patients <50 Years and ≥50 Years Admitted to a Single Centre: The Bergen Stroke Study. Stroke Res Treat (2011) 0.84

Ventricular enlargement and mild cognitive impairment in early Parkinson's disease. Mov Disord (2010) 0.84

Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data. CNS Neurosci Ther (2010) 0.84

The effect of physiologic derangement in patients with stroke treated with thrombolysis. J Stroke Cerebrovasc Dis (2008) 0.84

White matter hyperintensities and the course of depressive symptoms in elderly people with mild dementia. Dement Geriatr Cogn Dis Extra (2012) 0.84

Cortical changes associated with depression and antidepressant use in Alzheimer and Lewy body dementia: an MRI surface-based morphometric study. Am J Geriatr Psychiatry (2013) 0.83

Multispectral MRI segmentation of age related white matter changes using a cascade of support vector machines. J Neurol Sci (2012) 0.83

Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management. Drugs Aging (2013) 0.83